meglumine has been researched along with Diabetes Mellitus, Type 2 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Guo, YK; Li, Y; Shi, R; Wen, XL; Xu, HY; Yang, ZG | 1 |
| Ariga, R; Clarke, K; Ferreira, VM; Francis, JM; Greiser, A; Karamitsos, TD; Levelt, E; Liu, A; Mahmod, M; Neubauer, S; Piechnik, SK; Wijesurendra, RS | 1 |
| Frolov, VM; Peresadin, NA; Zelenyĭ, II | 1 |
| Del'tsova, EI; Gonchar, MG; Sabadosh, RV; Skripko, VD | 1 |
| Filippov, SI; Glushchenko, AV; Lukach, VN; Orlov, IuP | 1 |
| Hanitzsch, R; Klemenz, A; Markwardt, F; Peschke, E; Wolgast, S | 1 |
| Bravo-Nuevo, A; Huang, M; Kappler, F; Laury-Kleintop, L; Marcy, A; Mulgrew, J; Prendergast, GC; Reichman, M; Tobia, A | 1 |
| Arlart, IP; Gerlach, A; Hatopp, A; Klinger, S; Prodehl, P; von Kalle, T | 1 |
2 trial(s) available for meglumine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Effectiveness of Reamberin in correction of oxidative stress syndrome in patients with phlegmonous and gangrenous erysipelas against the background of the 2 type diabetes mellitus].
Topics: Adult; Cellulitis; Diabetes Mellitus, Type 2; Erysipelas; Female; Gangrene; Humans; Male; Meglumine; Middle Aged; Oxidative Stress; Succinates; Syndrome; Treatment Outcome | 2012 |
[Contrast-enhanced MR angiography (CEMRA) in peripheral arterial occlusive disease (PAOD): conventional moving table technique versus hybrid technique].
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Contrast Media; Diabetes Mellitus, Type 2; Female; Gadolinium; Humans; Image Enhancement; Imaging, Three-Dimensional; Leg; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Peripheral Vascular Diseases | 2004 |
6 other study(ies) available for meglumine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Impact of myocardial scars on left ventricular deformation in type 2 diabetes mellitus after myocardial infarction by contrast-enhanced cardiac magnetic resonance.
Topics: Adult; Aged; Contrast Media; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Female; Heart Disease Risk Factors; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardial Infarction; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Ventricular Function, Left | 2021 |
Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease.
Topics: Adenosine; Adult; Case-Control Studies; Contrast Media; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Early Diagnosis; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Microcirculation; Middle Aged; Myocardial Perfusion Imaging; Observer Variation; Organometallic Compounds; Predictive Value of Tests; Reproducibility of Results; Stroke Volume; Vasodilator Agents; Ventricular Function, Left | 2017 |
[The use of antihypoxant therapy for the complex surgical treatment of the gangrene-ischemic diabetic foot syndrome].
Topics: Adult; Algorithms; Antioxidants; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Gangrene; Humans; Ischemia; Limb Salvage; Male; Meglumine; Middle Aged; Monitoring, Physiologic; Reoperation; Retrospective Studies; Severity of Illness Index; Succinates; Treatment Outcome | 2013 |
[Efficiency of succinic acid infusion solutions in minor surgery].
Topics: Adult; Aged; Atherosclerosis; Diabetes Mellitus, Type 2; Female; Humans; Male; Meglumine; Middle Aged; Succinates; Systemic Inflammatory Response Syndrome; Time Factors | 2013 |
Effects of insulin on norepinephrine- and acetylcholine-induced membrane currents of pinealocytes from healthy Wistar and type 2 diabetic GK rats.
Topics: Acetylcholine; Animals; Diabetes Mellitus, Type 2; Extracellular Space; Insulin; Male; Meglumine; Membrane Potentials; Norepinephrine; Pineal Gland; Rats; Rats, Wistar; Sodium | 2014 |
Meglumine exerts protective effects against features of metabolic syndrome and type II diabetes.
Topics: Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Female; Meglumine; Metabolic Syndrome; Mice; Muscle, Skeletal; Myoblasts; Organ Size; Protective Agents; Protein Serine-Threonine Kinases; Triglycerides | 2014 |